Mesoporous silica nanoparticles as a drug delivery mechanism
Open Life Sciences · 15.05.2024 · 19 (1)
DOI: 10.1515/biol-2022-0867 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Open Life Sciences, online erschienen am 15.05.2024. Verfasst von Wei Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, …. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Research in intelligent drug delivery systems within the field of biomedicine promises to enhance drug efficacy at disease sites and reduce associated side effects. Mesoporous silica nanoparticles (MSNs), characterized by their large specific surface area, appropriate pore size, and excellent biocompatibility, have garnered significant attention as one of the most effective carriers for drug delivery. The hydroxyl groups on their surface are active functional groups, facilitating easy functionalization. The installation of controllable molecular machines on the surface of mesoporous silica to construct nanovalves represents a crucial advancement in developing intelligent drug delivery systems (DDSs) and addressing the issue of premature drug release. In this review, we compile several notable and illustrative examples of MSNs and discuss their varied applications in DDSs. These applications span regulated and progressive drug release mechanisms. MSNs hold the potential to enhance drug solubility, improve drug stability, and mitigate drug toxicity, attributable to their ease of functionalization. Furthermore, intelligent hybrid nanomaterials are being developed, featuring programmable properties that react to a broad spectrum of stimuli, including light, pH, enzymes, and redox triggers, through the use of molecular and supramolecular switches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, No. 1 West Huan-Hu Ro…
- Department of Pharmacy, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300072, China.
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, No. 10 of Poyang Lake Road, Tuanpo Xincheng West District, Tianjin 301617, China.
- School of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
Zitieren
APA
Zhang, W., Liu, H., Qiu, X., Zuo, F., & Wang, B. (2024). Mesoporous silica nanoparticles as a drug delivery mechanism. Open Life Sciences, 19(1). https://doi.org/10.1515/biol-2022-0867
Vancouver
Zhang W, Liu H, Qiu X, Zuo F, Wang B. Mesoporous silica nanoparticles as a drug delivery mechanism. Open Life Sciences. 2024;19(1). doi:10.1515/biol-2022-0867
BibTeX
@article{Zhang2024,
author = {Zhang, Wei and Liu, Hongwei and Qiu, Xilong and Zuo, Fanjiao and Wang, Boyao},
title = {Mesoporous silica nanoparticles as a drug delivery mechanism},
journal = {Open Life Sciences},
year = {2024},
volume = {19},
number = {1},
doi = {10.1515/biol-2022-0867}
}
EUVIMED